provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content
HomeHealth TopicNeurological

Neuroleptic Malignant Syndrome: Prevention, Causes, and Treatment

Sameer Hassamal, MDPatricia Pinto-Garcia, MD, MPH
Published on January 19, 2022

Key takeaways:

  • Neuroleptic malignant syndrome (NMS) is a rare condition that can happen when someone takes antipsychotic or antidepressant medications. 

  • People taking antipsychotic medications at high doses are more likely to develop NMS.

  • NMS is life-threatening, and its treatment requires hospitalization.  

Vaccine vial and syringe on a metal tray in a clinic. The background is blurry and unrecognizable.
Amornrat Phuchom/iStock via Getty Images

Neuroleptic malignant syndrome (NMS) is a condition that develops when medications block dopamine, a chemical in the brain. NMS is a rare but serious condition that can be fatal if it isn’t treated quickly. Several types of medications can cause NMS, but antipsychotics are the most common instigators. 

If you or someone you love is taking medications that can lower dopamine levels, here’s everything you need to know about NMS. 

What causes neuroleptic malignant syndrome?

NMS happens when dopamine levels in the brain drop quickly. Dopamine plays an important role in controlling:

  • Heart rate

  • Blood pressure

  • Breathing rates 

  • Body temperature

When dopamine levels are too low, the body has trouble with these important functions. This can lead to serious illness and even death. 

What medications are associated with neuroleptic malignant syndrome?

Several medications can lead to NMS, including certain antipsychotic and antidepressant medications. It’s important to remember that NMS is rare. It’s good to be aware of NMS, but don’t stop your medication without talking to your healthcare provider. It’s very likely that your medication’s benefits far outweigh your risk of developing NMS. 

Antipsychotic medications

Antipsychotics can treat schizophrenia, bipolar disorder, and depression. Higher-potency (strength) antipsychotics are more likely to cause NMS than lower-potency antipsychotics. 

Commonly prescribed higher-potency antipsychotics include: 

  • Haloperidol

  • Fluphenazine

  • Chlorpromazine

  • Trifluoperazine

  • Prochlorperazine

Antidepressant medications

Certain antidepressants used to treat depression and anxiety can cause NMS. These medications include:

  • Phenelzine

  • Amoxapine

  • Dosulepin

  • Desipramine

Huntington’s disease medications

Tetrabenazine is a drug used to treat Huntington's disease. Tetraneanzine reduces involuntary movements by decreasing dopamine. Although rare, it can cause NMS. 

Anti-nausea medications

While rare, certain medications used to treat nausea and vomiting can also cause NMS. These medications include:

Parkinson’s disease medications

Medications used to treat Parkinson’s disease improve symptoms by increasing dopamine levels. In this case, people develop NMS when these medications are stopped. These medications include:

If you have Parkinson’s disease and take these medications, never stop taking them without talking to your healthcare provider. You may need to slowly lower your dose over time to prevent side effects, including NMS. 

What is the ‘tetrad of symptoms’?

The “tetrad of symptoms” refers to the four most common symptoms of NMS, which are:

1) Fever

2) Rigid muscles

3) Confusion

4) Uncontrollable changes in heart rate, blood pressure, and breathing

These symptoms are severe and can be life-threatening. If your loved one is taking medication that can cause NMS and they suddenly develop fever, confusion, and they aren’t looking well, seek medical care right away. Your loved one may not be able to call for help themselves,

What’s the treatment for neuroleptic malignant syndrome? Is there a cure?

People with NMS need to be treated in a hospital. The first step is to stop all medications that decrease dopamine. People will also commonly receive treatment like:

  • Intravenous (IV) fluids

  • Oxygen therapy

  • Medications like lorazepam, dantrolene, and bromocriptine

Most episodes of NMS improve with treatment. Without treatment, mortality may be as high as 20%. So it’s important to get care right away. 

What can you do to lower your risk?

It’s unclear why some people get NMS and others don’t — even if they use the same medication. 

But there are some things you can do to lower your risk of developing NMS. If possible:

  • Use an antipsychotic that has less effect on your dopamine levels — like quetiapine, clozapine, or chlorpromazine.

  • Use the lowest dose of medications that decrease dopamine.

  • Avoid taking lithium if you are already taking an antipsychotic or antidepressant that lowers dopamine levels.

  • Try not to take more than one medication that decreases dopamine levels.

  • Drink enough fluids every day so your body can process your medication. 

The bottom line

Neuroleptic malignant syndrome is a rare but serious condition that can cause damage to the heart, brain, and lungs. NMS develops in some people who take medications that lower the amount of dopamine in the brain. Certain types of antipsychotics and antidepressants are more likely to cause NMS than others. To decrease your risk of developing NMS, try not to take more than one medication that decreases dopamine levels. 

why trust our exports reliability shield

Why trust our experts?

Sameer Hassamal, MD
Sameer Hassamal is an assistant professor of psychiatry at California University of Sciences and Medicine and Arrowhead Regional Medical Center. He is board certified in adult psychiatry, addiction psychiatry, and brain injury medicine by the American Board of Psychiatry and Neurology.
Patricia Pinto-Garcia, MD, MPH
Patricia Pinto-Garcia, MD, MPH, is a medical editor at GoodRx. She is a licensed, board-certified pediatrician with more than a decade of experience in academic medicine.
View All References (2)

Shiloh, R., et al. (2003). Precautionary measures reduce risk of definite neuroleptic malignant syndrome in newly typical neuroleptic-treated schizophrenia inpatients. International Clinical Psychopharmacology

Strawn, J., et al. (2007). Neuroleptic malignant syndrome. American Journal of Psychiatry.

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

Was this page helpful?

Subscribe and save.

Get prescription saving tips and more from GoodRx Health. Enter your email to sign up.

By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.